Arterial Thromboembolism » Cerebrovascular Disorders

Abstract Number: PB0016

“Red Cardiac versus White Atherosclerotic Thromboemboli in Acute Ischemic Stroke”: Challenging the Concept via a Large-scale, Detailed Multi-parametric Histological Analysis

S. Staessens¹, O. François², E. Boulleaux³, D. Corseaux³, L. Desender¹, A. Vandenbulcke¹, J. de Boer⁴, C. Vens⁴, A.-S. De Sloovere², T. Dewaele², P. Vanacker^5,6,7, S. Susen^3,8, K. Vanhoorelbeke¹, C. Cordonnier⁹, T. Andersson^2,10, S.F. De Meyer¹

Abstract Number: LPB0051

ACTIMIS Trial: Safety Interim Analysis Data of Glenzocimab, a Novel Antiplatelet Agent on Top of Acute Ischemic Stroke Standard of Care

M. Mazighi¹, A. Peeters², S. Richard³, C. Molina⁴, R. Lemmens⁵, D. Toni⁶, Y. Plétan⁷, M. Jandrot-Perrus⁸, A. Comenducci⁷, G. Avenard⁷, P. Lyrer⁹, M. Kohrmann¹⁰, ACTIMIS Study Group

Abstract Number: PO103

B-mode Ultrasound-guided Combined Catheter-based Q-switched-Nd: YAG Laser and Pulsed Low Level Dual Frequency Focused Ultrasound Thrombolytic Therapy Reduce Thrombus Content in the Arterial Atherothrombotic Stenosis

H. Mehrad^1,2, M. Farhoudi³

Abstract Number: OC 65.2

Changes in Prescription Patterns of Oral Anticoagulants and Clinical Outcomes among Newly Diagnosed Non-valvular Atrial Fibrillation Patients in the Netherlands

Q. Chen¹, M.M. Toorop¹, S.C. Cannegieter¹, W.M. Lijfering¹

Abstract Number: PB0018

Evaluation of the Need for Cytoreduction and its Potential Carcinogenicity in Children and Young Adults with Myeloproliferative Neoplasms

H.S. Choi¹, J. Hong², S.M. Hwang³, J.H. Lee⁴, Y. Ma¹, S.-A Kim⁴, J.Y. Lee⁴, J.-O. Lee⁴, S.-M. Bang⁴

Abstract Number: PO104

Extracorporeally Thrombolytic Therapy of Embolic Common Carotid Artery Using Q-switched Nd:YAG Laser and Confocal Dual Pulse Electrohydraulic Shock Waves Accompanied by PESDA Microbubbles Administration

H. Mehrad^1,2, M. Farhoudi³

Abstract Number: OC 65.3

Improving Outcomes with Integrated Care of Patients with Atrial Fibrillation and Multimorbidity Using Mobile Health Technology: A Report from the mAFA II Trial

Y. Guo¹, G.YH Lip²

Abstract Number: PB0015

Is Microvessel Perfusion Associated with Platelets in Acute Cerebrovascular Disorders?

P.P. Wadowski¹, C. Schörgenhofer², T. Rieder², S. Ertl¹, J. Pultar¹, W. Serles³, T. Sycha³, F. Mayer³, R. Koppensteiner¹, T. Gremmel¹, B. Jilma²

Abstract Number: PB0019

Long-term Outcome of Percutaneous or Surgical revascularization with and without Prior Stroke in patients with Three-vessel Disease

N. Xu¹, L. Jiang¹, C. Zhang¹, J. Xu¹, R. Liu¹, Y. Zhang¹, X. Zhao¹, R. Gao¹, L. Song¹, J. Yuan¹

Abstract Number: PB0024

miR-19a-3p Predicts Stroke Severity and miR-186-5p Might Be a Diagnostic Biomarker in Ischemic Stroke Patients with Hyper Platelet Reactivity

C. Eyileten¹, D. Jakubik¹, J. Jarosz-Popek^1,2, P. Czajka¹, M. Wolska¹, A. Fitas¹, A. Nowak¹, Z. Wicik³, D. Mirowska-Guzel¹, A. Członkowska⁴, M. Postuła¹

Abstract Number: PB0014

Natural Changes in CHA2DS2-VASc Scores in Newly Diagnosed Non-valvular Atrial Fibrillation Patients with Low Stroke Risk

Q. Chen¹, M.M. Toorop¹, S.C. Cannegieter¹, W.M. Lijfering¹

Abstract Number: LPB0003

Persistence Pattern to Oral Anticoagulants among Non-valvular Atrial Fibrillation Patients who Switched from Vitamin K Antagonists to Direct Oral Anticoagulants: A Cohort Study

M.M. Toorop¹, Q. Chen¹, M.J. Kruip^2,3, F.J. van der Meer¹, M. Nierman⁴, L. Faber⁵, L. Goede⁶, S.C. Cannegieter¹, W.M. Lijfering¹

Abstract Number: PB0023

Photodynamic Therapy with 5- Aminolevulinic Acid and B-mode Ultrasound-guided Catheter-based Low-level Red Laser Results in Cerebrovascular Neointimal Hyperplasia Regression

H. Mehrad^1,2, A. Sultan- Qurraie³

Abstract Number: PB0021

Platelet-derived microRNAs Are Increased after Transcatheter Aortic Valve Implantation and May Predict Adverse Outcomes in Patients with Heart Failure

C. Eyileten¹, A. Fitas¹, J. Jarosz-Popek^1,2, T. Adem¹, D. Jakubik¹, M. Wolska¹, A. Nowak¹, P. Czajka¹, M. Postuła¹, A. Gąsecka³

Abstract Number: OC 65.4

Prescription Patterns and Impact of Anticoagulant Therapy in Patients with Atrial Fibrillation who Had Active Cancer

C. Chai-Adisaksopha¹, A. Watanabe², P. Dilokthornsakul³, L. Navaravong², N. Chaiyakunapruk²

Abstract Number: PB0022

Role of the Interaction between Thrombophilia and Other Risk Factors in the Occurring of Ischemic Stroke in Young Patients: Algerian Restrospective Study about 75 Cases

M. El Horri¹, I. Khachaa¹, A. Chikh Khelifa¹, A. Berrah¹, M. Chekkal², F. Bemmoussat¹, L. Benmahdi¹, S.E. Belakehal¹

Abstract Number: LPB0004

Safety and Efficacy of Using Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with Pre-obesity and Obesity

Q. Chen¹, M.M. Toorop¹, S.C. Cannegieter¹, W.M. Lijfering¹

Abstract Number: LPB0002

Safety and Pharmacokinetics of Direct Oral Anticoagulants after Bariatric Surgery: A Systematic Review

R. Leong¹, D.K Chu^2,3, M.A Crowther², S. Mithoowani²

Abstract Number: PB0020

Single Centre Retrospective Chart Review to Examine the Management of Timing of Anticoagulation and Outcomes in Patients with Cerebral Venous Sinus Thrombosis

G. Mak¹, N. Chan¹, K. Perera¹

Abstract Number: PB0017

Soluble P-selectin is Associated with Increased Risk of Ischemic Stroke in Patients with Atrial Fibrillation on Hemodialysis: Results from the VIVALDI Study

O. Koenigsbruegge¹, S. Schmaldienst², M. Lorenz³, R. Klauser-Braun⁴, I. Pabinger¹, M. Säemann⁵, C. Ay¹